{"schema_version":"1","generated_at":"2026-11-21T21:33:02.518Z","data_as_of":null,"url":"https://www.findmykol.com/kol/david-warshal","json_url":"https://www.findmykol.com/kol/david-warshal/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"david-warshal","name":"David Warshal","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Cooper University Hospital","institution_url":"https://www.findmykol.com/institution/cooper-university-hospital","city":"Camden","state":"NJ","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"David Warshal is an Oncology physician affiliated with Cooper University Hospital. OpenAlex indexes 84 publications with 4,273 citations (h-index 19).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":84,"cited_by_count":4273,"h_index":19,"latest_activity_year":2025,"emerging":true,"source":"works"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":27,"shown":3,"withheld":24,"rows":[{"payer":"Eisai Inc.","program_year":2025,"amount_usd":251.25,"payment_count":2},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":136.26,"payment_count":3},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":31.6,"payment_count":2}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":6,"areas_shown":3,"areas":[{"area":"Sensory organs","share_pct":31,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":31,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":27}]},{"area":"Nervous system","share_pct":19.3,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":19.3,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":43}]},{"area":"Metabolism & gastrointestinal","share_pct":19,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":19,"drugs":[{"name":"Ondansetron Odt","share_pct":100}],"max_beneficiaries":40}]}],"care_setting":{"dominant":"mixed","data_year":2023,"office_pct":41.1,"facility_pct":58.9},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Molecular Classification of Endometrial Cancers (EC) and Association with Relapse-Free Survival (RFS) and Overall Survival (OS) Outcomes: Ancillary Analysis of GOG-0258","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.01.006","status":"verified"},{"title":"Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278)","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.03.005","status":"verified"},{"title":"OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.04.578","status":"verified"},{"title":"Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278)","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.02.023","status":"verified"},{"title":"Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.03.094","status":"verified"}],"source":"works"},"similar":[{"name":"Vineet Bhandari","slug":"vineet-bhandari","institution":"Cooper University Hospital","specialty":"Neonatal-Perinatal Medicine","url":"https://www.findmykol.com/kol/vineet-bhandari","json_url":"https://www.findmykol.com/kol/vineet-bhandari/profile.json"},{"name":"Christina Chu","slug":"christina-chu","institution":"Cooper University Hospital","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/christina-chu","json_url":"https://www.findmykol.com/kol/christina-chu/profile.json"},{"name":"Fred Rincon","slug":"fred-rincon","institution":"Cooper University Hospital","specialty":"Vascular Neurology","url":"https://www.findmykol.com/kol/fred-rincon","json_url":"https://www.findmykol.com/kol/fred-rincon/profile.json"},{"name":"Elyce Cardonick","slug":"elyce-cardonick","institution":"Cooper University Hospital","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/elyce-cardonick","json_url":"https://www.findmykol.com/kol/elyce-cardonick/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":24,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}